Top compounds associated with response to RP1-179P9.3


Feature Type Standardized
Nominal ANOVA
mRNA QS11 CTRPv2 pan-cancer AAC -0.13 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.1
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.064 0.1
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.055 0.1
mRNA masitinib CTRPv2 pan-cancer AAC 0.063 0.1
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.089 0.1
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.061 0.1
Download CSV